Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today highlighted data presented at the American Association ...

LAVAL, QC, April 21, 2026 /CNW/ - In recognition of AML World Awareness Day, Servier Canada is highlighting the progress made in precision medicine for Acute Myeloid Leukemia (AML). With TIBSOVO(R) ...

Add Yahoo as a preferred source to see more of our stories on Google. Tatiana Schlossberg's surprising revelation that she is battling terminal cancer has put a spotlight on the type of cancer with ...

Precision Biologics, Inc. announces a new target in Acute Myeloid Leukemia (AML) for CAR-NK therapy. Recent data for several human AML subtypes expressing truncated core 1 O-glycans will be presented ...

Despite advances in cancer treatment in recent years, five-year survival rates for acute myeloid leukemia (AML) remain low at just 30% on average, according to the National Cancer Institute. Factors ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people with acute myeloid leukemia (AML) overcome resistance to one of the most ...

Study from Japan shows near-tripling over 30-year period ...

Dagco added 451,240 shares, making Sellas its second-largest holding at 1.01% of portfolio weight. ・The stake increase comes ahead of AACR presentation of preclinical data on SLS009, Sellas’ CDK9 ...

Following her diagnosis in 2020, the content creator went viral for dancing every day throughout her acute myeloid leukemia ...